Effect of pretreatment by cardamom oil on in vivo percutaneous absorption of piroxicam gel: Pharmacokinetic analysis in rabbits

International Journal of Pharmaceutics

Volumn 134, Issue 1-2, 1996, Pages 183-191

  Huang, Yaw Bin ^a   Wu, Pao Chu ^a   Ko, Hsiu Man ^a   Tsai, Yi Hung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cardamom oil; Pharmacokinetic model; Piroxicam; Pretreatment

Indexed keywords

PENETRATION ENHANCING AGENT; PIROXICAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOLOGICAL MODEL; CARDAMOM; CONTROLLED STUDY; DRUG BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION;

EID: 0029920134     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04430-2     Document Type: Article

References (28)

1. Barry, B.W., Properties that influence percutaneous absorption. In: Dermatological Formulations. Percutaneous Absorption. Dekker, New York, 1983, pp. 127-233.
2. Barry, B.W. and Bennett, S.L., Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol., 39 (1987) 535-546.
3. Berner, B., Mazzenga, G.C., Otte, J.H., Steffens, R.J., Juang, R.-H. and Ebert, C.D., Ethanol:water mutually enhanced transdermal therapeutic system. II: skin permeation of ethanol and nitroglycerin. J. Pharm. Sci., 78 (1989) 402-407.
4. Corbo, M., Liu, J.C. and Chien, Y.W., Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci., 79 (1990) 584-587.
5. Cornwell, P.A. and Barry, B.W., Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol., 46 (1994) 261-269.
6. Fang, J.Y.,Wu, P.C., Huang, Y.B. and Tsai, Y.H., In vivo percutaneous absorption of capsaicin, nonivamide and sodium nonivamide acetate from ointment bases: pharmacokinetic analysis in rabbits. Int. J. Pharm., (1996) in press.
7. Gennaro, A.R., Remington's Pharmaceutical Sciences, 17th ed., Mack Publishing Company, Easton, Pennsylvania, 1985, pp. 1285.
8. Goodman, M. and Barry, B.W., Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. 1. Infinite dose technique. J. Invest. Dermatol., 91 (1988) 323-327.
9. Hadgraft, J., Penetration enhancers in percutaneous absorption. Pharm. Int., 5 (1984) 252-254.
10. Hatanaka, T., Shimoyama, M., Sugibayashi, K. and Morimoto, Y., Concentration- and time-dependent percutaneous absorption enhancing effect of ethanol. Yakuzaigaku, 52 (1992) 215-223.
11. Hosoya, K.I., Shudo, N., Sugibayashi, K. and Morimoto, Y., Effect of azone on the percutaneous absorption of 5-flurouracil from gels in hairless rats. Chem. Pharm. Bull., 35 (1987) 726-733.
12. Hsu, L.R., Tsai, Y.H. and Huang, Y.B., The effect of pretreatment by penetration enhancers on the in vivo percutaneous absorption of piroxicam from its gel form in rabbits. Int. J. Pharm., 71 (1991) 193-200.
13. Huang, Y.B., Wu, P.C., Ko, H.M. and Tsai, Y.H., Cardamom oil as skin permeation enhancer for indomethacin, piroxicam and diclofenac. Int. J. Pharm., 126 (1995) 111-112.
14. Huang, Y.B., Wu, P.C., Ko, H.M. and Tsai, Y.H., Effect of pretreatment by cardamom oil on in vitro percutaneous penetration of piroxicam gel. Int. J. Pharm., (1996) in press.
15. Hwang, C.C. and Danti, A.G., Percutaneous absorption of flufenamic acid in rabbits: effect of dimethylsulfoxide and various nonionic surface-active agents. J. Pharm. Sci., 72 (1983) 857-860.
16. Kurihara-Bergstrom, T., Knutson, K., DeNoble, L.J. and Goates, C.Y., Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm. Res., 7 (1990) 762-766.
17. Naito, S.I. and Tsai, Y.H., Percutaneous absorption of indomethacin from ointment bases in rabbits. Int. J. Pharm., 8 (1981) 263-276.
18. Obata, Y., Takayama, K., Okabe, H. and Nagai, T., Effect of cyclic monoterpenes on percutaneous absorption in the case of a water-soluble drug (diclofenac sodium). Drug Design Deliv., 6 (1990) 319-328.
19. Obata, Y., Takayama, K., Machida, Y. and Nagai, T., Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. Drug Design Deliv., 8 (1991) 137-144.
20. Ogiso, T., Ito, Y., Iwaki, M. and Atago, H., A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug deposition kinetics. J. Pharm. Sci., 78 (1989) 319-323.
21. Okabe, H., Obata, Y., Takayama, K. and Nagai, T., Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Design Deliv., 6 (1990) 229-238.
22. Takada, K., Yoshikawa, H. and Muranishi, S., Pharmacokinetic analysis of plasma drug level data obtained from a transdermal therapeutic system with a complex absorption model. Int. J. Pharm., 65 (1990) 159-167.
23. Takayama, K. and Nagai, T., Simultaneous optimization for several characteristics concerning percutaneous absorption and skin damage of ketoprofen hydrogels containing d-limonene. Int. J. Pharm., 74 (1991) 115-126.
24. Tsai, Y.H., Hsu, L.R. and Naito, S.I., Percutaneous absorption of piroxicam and its main metabolite in plasma and urine by high performance liquid chromatography. Int. J. Pharm., 24 (1985) 101-108.
25. Williams, A.C. and Barry, B.W., Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res., 8 (1991b) 17-24.
26. Williams, A.C. and Barry, B.W., The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int. J. Pharm., 74 (1991b) 157-168.
27. Yamada, M., Uda, Y. and Tanigawars, Y., Mechanism of enhancement of percutaneous absorption of mosidomine by oleic acid. Chem. Pharm. Bull., 35 (1987) 3399-3406.
28. Yamane, M.A., Williams, A.C. and Barry, B.W., Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int. J. Pharm., 116 (1995) 237-251.